or Try an Advanced Search...

    Technical Analysis for ACXP - Acurx Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    F 1.32 -5.04% -0.07
    ACXP closed down 16.77 percent on Wednesday, November 20, 2024, on 17.43 times normal volume. The bears made the stock sink to a new 52-week low.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical ACXP trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing Low Bearish -5.04%
    Expansion Breakdown Bearish Swing Setup -5.04%
    Reversal New Lows Setup Bearish Swing Setup -5.04%
    Volume Surge Other -5.04%
    Wide Range Bar Range Expansion -5.04%
    Lower Bollinger Band Walk Weakness -5.04%
    New 52 Week Low Weakness -5.04%
    BB Squeeze Ended Range Expansion -5.04%
    Outside Day Range Expansion -5.04%
    Gapped Up Strength -5.04%
    Older End-of-Day Signals for ACXP ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown about 2 hours ago
    Down 5% about 3 hours ago
    Gap Up Closed about 3 hours ago
    Down 3% about 3 hours ago
    Down 2 % about 3 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    ACXP Chart by TradingView
    Basic chart:

    Profile

    Acurx Pharmaceuticals, LLC, a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The company is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumoniae. The company was founded in 2017 and is based in Staten Island, New York.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Health Care Antibiotics Bacterial Infections Staphylococcus Aureus Methicillin Gram Positive Bacteria Vancomycin

    Is ACXP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 20 Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset
    Nov 18 Acurx Sponsored and Participated in the Peggy Lillis Foundation Inaugural CDI Scientific Symposium and Presented Ibezapolstat Ph2b Clinical Data Update
    Nov 14 Acurx Pharmaceuticals Inc (ACXP) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...
    Nov 13 Acurx Pharmaceuticals GAAP EPS of -$0.17
    Nov 13 Acurx Pharmaceuticals, Inc. (ACXP) Q3 2024 Earnings Call Transcript
    Nov 13 Acurx Pharmaceuticals, Inc. Reports Third Quarter 2024 Results and Provides Business Update
    Nov 13 Earnings Scheduled For November 13, 2024
    Oct 31 New to The Street to Air as Sponsored Programming on Bloomberg Friday, November 1st, Featuring Modular Medical, OriginClear With Shark Tank's Kevin Harrington, Acurx Pharmaceuticals, the Sustainable Green Team, and SEKUR’s "Hack of the Week"
    Oct 28 New to The Street on Fox Business Premieres Exclusive Sponsored Programming Tonight Featuring Modular Medical (NASDAQ:MODD), Acurx Pharmaceuticals (NASDAQ:ACXP), and LightPath Technologies (NASDAQ:LPTH)
    Oct 21 Acurx Ready To Expand Pipeline With Anthrax Treatment
    See more ACXP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.28
    52 Week Low 1.18
    Average Volume 61,668
    200-Day Moving Average 2.22
    50-Day Moving Average 1.93
    20-Day Moving Average 1.81
    10-Day Moving Average 1.75
    Average True Range 0.12
    RSI (14) 14.53
    ADX 29.4
    +DI 5.33
    -DI 46.07
    Chandelier Exit (Long, 3 ATRs) 1.61
    Chandelier Exit (Short, 3 ATRs) 1.53
    Upper Bollinger Bands 2.05
    Lower Bollinger Band 1.58
    Percent B (%b) -0.4
    BandWidth 25.96
    MACD Line -0.09
    MACD Signal Line -0.06
    MACD Histogram -0.0338
    Fundamentals Value
    Market Cap 19.14 Million
    Num Shares 13.8 Million
    EPS -1.05
    Price-to-Earnings (P/E) Ratio -1.32
    Price-to-Sales 0.00
    Price-to-Book 10.74
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.22
    Resistance 3 (R3) 2.24 1.98 2.08
    Resistance 2 (R2) 1.98 1.77 1.97 2.03
    Resistance 1 (R1) 1.69 1.64 1.56 1.67 1.99
    Pivot Point 1.43 1.43 1.37 1.42 1.43
    Support 1 (S1) 1.14 1.22 1.01 1.12 0.79
    Support 2 (S2) 0.88 1.09 0.87 0.75
    Support 3 (S3) 0.59 0.88 0.70
    Support 4 (S4) 0.57